Form 4 for HQL abrdn Life Sciences Investors
Accepted 2025-09-17 00:00:00 ET · period of report 2025-09-15 · accession 0001510281-25-000488 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-09-17 | 2025-09-15+ | HQL | Saba Capital Management, L.P. | 10% | S - Sale | $14.03 | -2,726 | 2.95M | -0.1% | -$38.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-15 | S | D | 700 | $14.13 | 2,952,807 | I - | — | — | |
| 2 | Common | Common Stock | 2025-09-16 | S | D | 2,026 | $13.99 | 2,950,781 | I - | — | — |